Treatment with Sispera for 16 weeks overseas showed a 67% reduction in the melanin index of melasma lesions and a 58% reduction in melasma area. (Female and male patients aged 18-50 years with skin color type "Fitzpatrick skin type III, IV, and V" common in Japanese)